Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.Dusa completes enrollment for Phase IIb acne trial
The study’s objective is to determine and compare the safety and efficacy of multiple broad area photodynamic therapy (PDT) treatments with Levulan Kerastick in combination with BLU-U brand
The study’s objective is to determine and compare the safety and efficacy of multiple broad area photodynamic therapy (PDT) treatments with Levulan Kerastick in combination with BLU-U brand
The Phase I study is a randomized, double-blind and placebo-controlled single ascending dose study to evaluate the compound’s safety, tolerability and pharmacokinetic profile after oral administration. The study
Sherri Oberg, president and CEO of Acusphere, said: “We are very pleased with the terms of this transaction, which establishes a strong value for part of our technology
As part of the transaction, Alnylam Pharmaceuticals and the Roche Venture Fund will each invest $5 million in Tekmira at a price of $2.40 per Tekmira share. At
The study (TAPAS) found that most acute myocardial infarction (AMI) patients with ST-segment elevation achieved better reperfusion and clinical outcomes when receiving thrombus aspiration before standard acute myocardial
The patented, high-tech medical device is said to alleviate fatigue and pain and has received the CE mark in Europe earlier. KFH Energy utilizes a unique form of
The lawsuit is in response to Actavis’s notice to Endo and Penwest, announced on February 15, 2008, advising of the filing by Actavis of an ANDA containing a
The treatment uses Vical technology to deliver a gene encoding hepatocyte growth factor, a human protein that causes growth of blood vessels in areas of restricted blood flow.
Each unit consists of a common share of the company and one common share purchase warrant. Each warrant entitles the holder thereof to purchase one common share at
Bupropion Hydrochloride extended-release tablets (SR), available in 150mg strength, are the generic equivalent of Wellbutrin SR and are indicated for the treatment of major depressive disorder. Bupropion Hydrochloride